CLINICAL ROLE -
Kennedy Ferruggia is an assistant editor at Pharmacy Times®. She graduated from The College of New Jersey in 2023 in journalism and marketing. Prior to this position, she worked as a pharmacy associate for community pharmacies.
Semaglutide Could Offer Potential Treatment for Cocaine Use Disorder
Research reveals semaglutide's potential to reduce cocaine-seeking behavior in rats, suggesting a promising avenue for treating cocaine dependency in humans.
Read More
Study: How Stress and Diet Disrupt a Brain Circuit to Increase Diabetes Risk
Researchers uncover a brain circuit linking stress to increased blood glucose, revealing insights into stress's role in type 2 diabetes (T2D) development.
Gemcitabine Intravesical System Receives FDA Approval for Non–Muscle Invasive Bladder Cancer
The FDA approves a groundbreaking gemcitabine system, offering new hope for patients with BCG-unresponsive bladder cancer.
Single-Dose LSD Therapy Shows Promise for Generalized Anxiety Disorder
MM120 shows promise in treating generalized anxiety disorder, demonstrating significant symptom relief and a potential shift in psychiatric treatment approaches.
FDA Approves Expanded Use of Vonvendi for VWD in Adults and Children
FDA expands Vonvendi use for von Willebrand disease (VWD), enhancing treatment options for adults and children to manage bleeding effectively.
RSV Immunization Shows Cardiorespiratory Benefits in Adults Aged 60 and Older
RSV vaccination shows promise in reducing cardiorespiratory hospitalizations among older adults, highlighting potential heart and lung health benefits.
FDA Grants Breakthrough Therapy Designation to Olomorasib With Pembrolizumab for NSCLC
The FDA designates olomorasib as a breakthrough therapy, enhancing treatment options for advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutations.
Study Finds Greater Risk of Death From Type 2 Diabetes in Patients With Learning Disabilities
Individuals with learning disabilities face a heightened risk of severe type 2 diabetes (T2D), leading to increased mortality despite better glycemic control.
RSV Vaccination Could Protect Older Adults From Hospitalization Across Multiple RSV Seasons
A single dose of an RSV vaccine significantly reduces hospitalization risk for older adults, offering protection for 2 seasons against severe infections.
Fitness, Lean Mass Linked to Reduced Anxiety and Depression in Children
Research reveals associations between body composition, fitness, and mental health in children, highlighting the impact of obesity on anxiety and depression.
Enlicitide Offers a New Oral Option for Managing High Cholesterol
A new oral PCSK9 inhibitor, enlicitide, shows promise in significantly lowering LDL cholesterol, offering hope for hypercholesterolemia management and cardiovascular health.
Abemaciclib Plus Endocrine Therapy Improves Overall Survival in High-Risk Early Breast Cancer
Abemaciclib significantly enhances overall survival in high-risk HR+, HER2- early breast cancer, establishing a new standard of care.
New Clinical Guidance Recommends Vaccines to Protect Cardiovascular Patients From Respiratory Illness
Vaccination is vital for adults with heart disease to prevent severe respiratory illnesses like RSV, influenza, and COVID-19, enhancing overall health outcomes.
Updated Diabetes Guidelines Prioritize SGLT-2 and GLP-1 Medications to Reduce Cardiovascular, Kidney Risk
An international BMJ panel recommended broader use of SGLT-2 inhibitors and GLP-1 receptor agonists.
FDA Approves 3-Month Leuprolide Mesylate 21-mg Formulation for Advanced Prostate Cancer
The FDA has approved a ready-to-use long-acting injectable formulation that is administered every 3 months as a treatment for advanced prostate cancer.
Rising 340B Costs Drive Employer Spending and Spark Calls for Reform
Employers are facing higher costs and employees higher premiums as 340B’s growth drives lost rebates and rising drug prices.
New Nanoparticle Treatment Shows Promise for Preventing Rheumatoid Arthritis Flares
An immunomodulatory nanoparticle called Agg-CLNP has been shown to effectively prevent disease onset for rheumatoid arthritis (RA).
FDA Approves Generic Version of Liraglutide Injection, a GLP-1 for Weight Loss
Generic liraglutide injection is the first GLP-1 indicated for weight loss.
COVID-19 Vaccination Could Lower Risk of Developing Asthma
COVID-19 vaccination significantly reduces the risk of asthma and other airway inflammatory diseases, offering vital protection against respiratory complications.
Orforglipron's Success in Phase 3 Trial Triggers Regulatory Submissions for Obesity Treatment
Orforglipron is an effective treatment, leading to significant body weight reduction and improved glycemic control.
More Potassium, Less Pressure: The Diet-Hypertension Link
Increasing dietary potassium, such as from bananas, may lower blood pressure more effectively than reducing sodium alone.
A High-Performance Room-Temperature Acetone Gas Sensor Could Aid Diabetes Detection
The sensor detects acetone levels in the breath to indicate diabetes.
Calls Grow for Transparency and Clearer Patient Definitions to Protect 340B’s Safety-Net Mission
Expert emphasizes the need for stronger transparency and patient definitions in the 340B program.
Dynavax’s Z-1018 Shingles Vaccine Candidate Shows Promising Immune Response and Safety in Early Trial
A novel shingles vaccine candidate demonstrated positive top-line results of antibody and CD4⁺ T-cell vaccine responses.
Understanding Appetite-Controlling Amylin Receptors Could Aid Development of Future Weight Loss Drugs
A better understanding of the activation of amylin receptors is a step forward for developing new drugs.
RSV-Associated Acute Respiratory Infections Show Comparable Outcomes to Influenza in Older Adults
RSV causes a significant burden of acute respiratory infections in older adults.
FDA Expands Evolocumab to Treat Adults at Increased Risk for Major Adverse Cardiovascular Events
Evolocumab is now indicated for adults at increased risk for major adverse cardiovascular events (MACE).
Study Reveals Subtle Heart Muscle Dysfunction in Bipolar Disorder Patients
Individuals with bipolar disorder are at nearly a 2-fold higher risk of heart failure, which is marked as the main cause of premature cardiovascular mortality.
RSVpreF Vaccine Is Well-Tolerated in Adults, Demonstrating Favorable Safety Profile
RSVpreF was well tolerated in nonpregnant and pregnant individuals aged 18 years and older.
Orforglipron Shows Positive Efficacy, Tolerability in Weight Management
The oral glucagon-like peptide agonist-1 met its primary end point and all secondary end points in a randomized, double-blind, placebo-controlled clinical trial for weight management.